intrahepatic cholangiocarcinoma
Conditions
Interventions
Intervention Group:Regional lymph node dissection
Control Group:None
Sponsors
The First Affiliated Hospital, Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients between 18 and 80 years of age; 2. Preoperative imaging and laboratory examinations are diagnosed as intrahepatic cholangiocarcinoma, and postoperative pathology is diagnosed as intrahepatic cholangiocarcinoma; 3. Patients with intrahepatic cholangiocarcinoma whose preoperative imaging evaluation is resectable and postoperative pathology confirmed R0 resection; 4. No lymph node metastasis other than regional lymph nodes is found in preoperative imaging and intraoperative evaluation; 5. Child-Pugh score is A or B; 6. The volume of residual liver is more than 30%; 7. ASA classification is 1-4 level; 8. Patients have autonomy, can understand and voluntarily sign written informed consent and can complete the follow-up plan; 9. Female patients of gestational age should be excluded from pregnancy; 10. The written informed consent should be signed before the screening stage of trial.
Exclusion criteria
Exclusion criteria: 1. The patient has obvious heart, lung, brain, or kidney insufficiency, who cannot tolerate surgery; 2. The patient has or is currently combined with other malignant tumors; 3. Female patients who are pregnant or breastfeeding; 4. The investigator judges that it is not suitable to participate in this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative 5-year overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative 3- and 5-year recurrence-free survival;Postoperative 3-year overall survival;Postoperative complications and 30-day mortality;Postoperative chemotherapy effect; | — |
Countries
China
Contacts
Public ContactXiao-Yu Yin
The First Affiliated Hospital, Sun Yat-Sen University
Outcome results
None listed